Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Transfection Reagents And Equipment Market Growth From $1.93 Billion In 2026 To $2.97 Billion By 2030 At A CAGR Of 11.3%#_x000D_
The transfection reagents and equipment market size has observed rapid expansion in recent years. It is projected to increase from $1.74 billion in 2025 to $1.93 billion in 2026, at a compound annual growth rate (CAGR) of 11.2%. The historical growth of this market can be ascribed to several factors, including the escalation of molecular biology research activities, the increased utilization of cell-based assays, the growth in recombinant protein production, the rising trend in academic and industrial genomics research, and the availability of advanced transfection chemistries._x000D_
_x000D_
The transfection reagents and equipment market size is projected to experience rapid expansion over the next few years. This market is anticipated to reach a value of $2.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. The growth observed during the forecast period can be primarily attributed to the increasing integration of CRISPR and gene therapy research, a rising demand for scalable transfection platforms, the ongoing development and expansion of biopharmaceutical pipelines, augmented investment in precision medicine, and increased automation within life science laboratories. Prominent trends throughout the forecast period include a greater uptake of high-efficiency transfection reagents, a growing requirement for gene editing-compatible delivery systems, an increasing reliance on non-viral transfection methods, the proliferation of automated transfection instruments, and a heightened emphasis on cell-type specific transfection solutions._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Transfection Reagents And Equipment Market Growth Backed By Core Demand Fundamentals#_x000D_
The increasing number of cancer patients globally is anticipated to propel the expansion of the transfection reagents and equipment market. Cancer is defined as a group of diseases characterized by cells that grow abnormally and without control. Transfection reagents are frequently utilized in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, enabling researchers to investigate various aspects of cancer biology, including gene expression studies, gene silencing, drug screening, and target validation. For instance, in July 2024, projections released by Cancer Research UK, a UK-based cancer charity, indicated that cancer incidence rates in the United Kingdom are expected to rise for the majority of types between 2023-2025 and 2038-2040. These increases range from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are predicted to decline, with reductions spanning from 2% for lung cancer to 27% for mesothelioma. Consequently, the rising worldwide count of cancer patients is a significant driver for the growth of the transfection reagents and equipment market._x000D_
_x000D_
#Transfection Reagents And Equipment Market Segment Performance And Emerging Opportunities#_x000D_
The transfection reagents and equipment market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Instruments, Reagent And Kits_x000D_
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules_x000D_
3) By End User: Biopharma, Contract Research Organizations (CROs), Academia_x000D_
_x000D_
Subsegments:_x000D_
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems_x000D_
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits_x000D_
_x000D_
#Transfection Reagents And Equipment Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Leading companies operating in the transfection reagents and equipment market are concentrating on developing innovative advancements, such as GMP-grade AAV transfection reagents, to improve viral vector production efficiency and support large-scale gene therapy manufacturing. A GMP-grade AAV transfection reagent is a regulatory-compliant chemical formulation designed to enable high-efficiency genetic material delivery into suspension cell cultures for the scalable production of recombinant adeno-associated virus vectors. For instance, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, received U.S. Food and Drug Administration Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade. This reagent demonstrates substantially higher viral titers and significantly improved full capsid ratios across multiple adeno-associated virus serotypes, offering superior performance relative to standard formulations. It further enhances manufacturing efficiency by achieving comparable vector yields with reduced reagent usage while adhering to stringent regulatory and quality requirements suitable for clinical and commercial gene therapy production._x000D_
_x000D_
#Transfection Reagents And Equipment Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc. _x000D_
_x000D_
#View The Full Transfection Reagents And Equipment Market Report:#_x000D_
_x000D_
#Transfection Reagents And Equipment Market Regional Distribution: Which Areas Power Market Growth?#_x000D_
North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.